prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) SENTINEL LYMPH NODE #1, RIGHT, NOT BLUE: One lymph node, no tumor present (0/1). Cytokeratin immunohistochemical stain is negative. (B) SENTINEL LYMPH NODE #2, RIGHT: One lymph node, no tumor present (0/1). Cytokeratin immunohistochemical stain is negative. (C) SENTINEL LYMPH NODE #3, RIGHT: One lymph node, no tumor present (0/1). Cytokeratin immunohistochemical stain is negative. (D) IGHT'BREAST SEGMENTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA OF THE BREAST, MODIFIED BLACK'S NUCLEAR GRADE 1,. WELL DIFFERENTIATED. INVASIVE LOBULAR CARCINOMA MEASURES 1.7 CM IN MAXIMUM DIMENSION. INVASIVE LOBULAR CARCINOMA IS 5 MM FROM THE SUPERFICIAL MARGIN OF. RESECTION, 5 MM FROM THE LATERAL MARGIN OF RESECTION, AND 5 MM. FROM THE INFERIOR MARGIN OF RESECTION. All other margins widely free of tumor. Atypical lobular hyperplasia. Fibrocystic changes. Changes consistent with prior biopsy site. (E) SECOND SUPERFICIAL INFERIOR LATERAL MARGIN: Fibrocystic changes. ADDITIONAL INFERIOR MARGIN: Atypical lobular hyperplasia. Fibrocystic changes. (G) LEFT BREAST EXCISIONAL BIOPSY: LOBULAR CARCINOMA IN SITU, CLASSIC TYPE. Changes consistent with prior biopsy site. Fibrocystic changes. Entire report and diagnosis completed by. COMMENT. Prognostic/predictive markers were performed on the patient's diagnostic biopsy. GROSS DESCRIPTION. (A) SENTINEL LYMPH NODE #1, NOT BLUE, IN VIVO 259, EX VIVO 332 - A tan-pink lymph node is 0.8 x 0.6 x 0.6 cm. The. specimen is serially sectioned and two touch preps are performed. Total A. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT ON TOUCH PREPS. SENTINEL LYMPH NODE #2, RIGHT, BLUE, IN VIVO 21, EX VIVO 17 - A tan-pink lymph node with blue dye is 0.8 X 0.5 x. 0.5 cm. The specimen is serially sectioned and two touch preps are performed. Total B. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT ON TOUCH PREPS. (C) SENTINEL LYMPH NODE #3, RIGHT, NOT BLUE, IN VIVO 50, EX VIVO 71 - A tan-pink lymph node is 0.7 x 0.5 X 0.5 cm. The specimen is serially sectioned and two touch preps are performed. Total C. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT. (D) RIGHT SEGMENTAL MASTECTOMY, SHORT STITCH SUPERIOR, LONG STITCH MEDIAL - An oriented right segmental. mastectomy specimen (6.0 x 6.0 x 3.0 cm). The specimen is oriented as short stitch superior, long stitch medial. The specimen is serially sectioned sequentially from lateral to medial aspect in seven slices. The cut surface reveals the. most lateral aspect (slice #1) towards medial aspect (slice #5), a white firm lesion (1.5 x 1.0 cm). The lesion is distant. approximately 0.5 cm from closest to superficial margin, 0.4 cm from closest lateral margin, 0.4 cm from closest inferior margin,. 1.5 cm from closest superior margin, and 2.0 cm from closest deep margin. INK CODE: Superficial - yellow, superior - blue, inferior - green, medial and lateral - red, and deep margin - black. SECTION CODE: Slice #1, most lateral aspect, D1-D3, in perpendicular sections; slice #2, D4, tumor including superficial. margin; D5, superior margin; D6, inferior margin; D7, deep margin; slice #3, D8, tumor including superficial margin; D9, section. including superior and deep margin; D10, section including superficial and inferior margin; slice #4; D11, tumor including. superficial. margin; D12, section including superior and deep margin; D13, section including inferior and deep margin; D14, section. including deep margin; slice #5; D15, tumor including superficial and superior margin; D16, section including superior and deep. margin; D17, section including superficial and inferior margin, slice #6; D18, section adjacent to the tumor, slice #7; D19, D20,. representative sections in perpendicular, most medial aspect. (E) SECOND SUPERFICIAL INFERIOR AND LATERAL MARGINS CLIPS ON TRUE MARGIN, SHORT STITCH ANTERIOR,. LONG STITCH SUPERIOR - An oriented irregular fragment of adipose tissue 4.0 x 4.0 x 0.8 cm. The specimen is oriented as clip. on true margin, short stitch anterior, long stitch superior. The specimen is serially sectioned sequentially from superior to inferior. INK CODE: Anterior-yellow, true margin-black. SECTION CODE: E1-E7, entirely submitted from superior to inferior. (F). ADDITIONAL INFERIOR MARGIN CLIPS MARK TRUE MARGIN - An oriented irregular fragment of adipose tissue (3.5 x 2.0. x 0.8 cm). The specimen is oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned. and entirely submitted in F1-F4. (G) LEFT EXCISIONAL BIOPSY, SHORT STITCH SUPERIOR, LONG STITCH MEDIAL - An oriented left excisional biopsy. specimen (3.0 x 3.0 x 2.0 cm). The specimen is oriented as short stitch superior, long stitch medial. The specimen is serially sectioned sequentially from medial to lateral aspect in six slices. The cut surface reveals fibrous. area and also on slice #3, a surgical coil is present, distant approximately 0.5 cm from closest superior margin, 0.7 cm from. closest superficial margin and 0.5 cm from closest deep margin. No tumor is grossly identified. INK. CODE: Superficial - yellow, superior - blue, inferior - green, medial and lateral - red, and deep margin - black. SECTION. CODE: Slice #1, most medial aspect, entirely submitted in perpendicular in G1-G3. Slice #2, G4, superior. aspect including margin; G5, inferior aspect including margin; slice #3, G6, superior aspect including margin; G7, inferior aspect. including margin; slice #4, G8, superior aspect, including margin; G9, inferior aspect, including margin; slice #5, G10, superior. aspect including margin; G11, inferior aspect including margin; slice #6, most lateral aspect; G12, G13, entirely submitted in. perpendicular. CLINICAL HISTORY. Bilateral segmental. SNOMED CODES. "Some tests reported here may have been developed and performance characteristics determined by. 1. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration.". Released by: Start of ADDENDUM. ADDENDUM. Addendum completed by. This report is issued to give immunohistochemistry results. Immunohistochemical staining is performed on a representative. formalin-fixed, paraffin-embedded section of INVASIVE LOBULAR CARCINOMA, right breast, block D4. MARKER. % POSITIVE SCORE. Estrogen Receptor. Positive. 90 %. N/A. Progesterone Receptor. Positive. 80 %. N/A. HER-2/neu. overexpression. Negative. 0 %. Ki-67. High (>35%). 65 %. N/A. FOOTNOTE. Estrogen receptor was assessed by immunohistochemistry using antibody 6F11 i. receptor was assessed by immunohistochemistry using antibody PgR1294. HER-2/neu was assessed by immunohistochemistry using antibody AB8. Ki-67 was assessed by immunohistochemistry using antibody MIB1. Released by:

expanded version (tokens=2251) : 
 According to the breast pathology report, the patient has invasive lobular carcinoma of the breast, with a maximum dimension of 1.7 cm and modified Black's nuclear grade of 1, which is considered well-differentiated with no mention of necrosis. The subtype is LumB. Atypical lobular hyperplasia and fibrocystic changes are also noted in the report. The lymphovascular invasion and calcification are not mentioned in the report. 

The histological grade and nuclear grade are not explicitly mentioned, but the modified Black's nuclear grade of 1 implies a low-grade tumor. Tumor-infiltrating lymphocytes are not mentioned in the report.

The receptor status of the biopsy shows that the estrogen receptor is positive (90% score), the progesterone receptor is positive (80% score), HER-2/neu overexpression is negative (0% score), and the Ki-67 proliferation index is high (>35%) with a 65% score. Hormone receptor status was evaluated using immunohistochemistry with antibodies 6F11 and PgR1294, while HER-2/neu was assessed using antibody AB8, and Ki-67 was assessed using antibody MIB1. 

Three sentinel lymph nodes were removed, and none of them had any tumor (0/1), based on cytokeratin immunohistochemical staining. Additionally, a biopsy of the left breast showed lobular carcinoma in situ of the classic type, and changes consistent

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2397) : 
 The breast pathology report confirms a diagnosis of invasive lobular carcinoma of the breast, subtype LumB, with no necrosis or lymphovascular invasion. The tumor grade is well-differentiated, and three sentinel lymph nodes are negative for cancer. Hormone receptor status is positive for estrogen and progesterone, negative for HER2/neu overexpression, with a high Ki-67 proliferation index. The report also notes atypical lobular hyperplasia and fibrocystic changes.

